This photo shows the Pfizer company logo at the company’s headquarters in New York. (AP Photo | Richard Drew, File)

This photo shows the Pfizer company logo at the company’s headquarters in New York. (AP Photo | Richard Drew, File)

Pfizer says early data signals COVID-19 vaccine is effective

But the announcement does not mean a vaccine is imminent

Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.

Monday’s announcement doesn’t mean a vaccine is imminent: This interim analysis, from an independent data monitoring board, looked at 94 infections recorded so far in a study that has enrolled nearly 44,000 people in the U.S. and five other countries.

Pfizer Inc. did not provide any more details about those cases, and cautioned the initial protection rate might change by the time the study ends. Even revealing such early data is highly unusual.

“We’re in a position potentially to be able to offer some hope,” Dr. Bill Gruber, Pfizer’s senior vice-president of clinical development, told The Associated Press. “We’re very encouraged.”

Authorities have stressed it’s unlikely any vaccine will arrive much before the end of the year, and limited initial supplies will be rationed.

The shots made by Pfizer and its German partner BioNTech are among 10 possible vaccine candidates in late-stage testing around the world — four of them so far in huge studies in the U.S. Another U.S. company, Moderna Inc., also has said it hopes to be able to file an application with the Food and Drug Administration later this month.

Volunteers in the final-stage studies, and the researchers, don’t know who received the real vaccine or a dummy shot. But a week after their second required dose, Pfizer’s study began counting the number who developed COVID-19 symptoms and were confirmed to have the coronavirus.

Because the study hasn’t ended, Gruber couldn’t say how many in each group had infections. Doing the math, that would mean almost all the infections counted so far had to have occurred in people who got the dummy shots.

Pfizer doesn’t plan to stop its study until it records 164 infections among all the volunteers, a number that the FDA has agreed is enough to tell how well the vaccine is working. The agency has made clear that any vaccine must be at least 50% effective.

No participant so far has become severely ill, Gruber said. Nor could he provide a breakdown of how many of the infections had occurred in older people, who are at highest risk from COVID-19.

Participants were tested only if they developed symptoms, leaving unanswered whether vaccinated people could get infected but show no symptoms and unknowingly spread the virus.

FDA has required that U.S. vaccine candidates be studied in at least 30,000 people. In addition to adequate numbers of older adults, those studies must also include other groups at high risk, including minorities and people with chronic health problems.

And it told companies they must track half their participants for side effects for at least two months, the time period when problems typically crop up. Pfizer expects to reach that milestone later this month, but said Monday no serious safety concerns have been reported.

Because the pandemic is still raging, manufacturers hope to seek permission from governments around the world for emergency use of their vaccines while additional testing continues — allowing them to get to market faster than normal but raising concerns about how much scientists will know about the shots.

The FDA’s scientific advisers last month said they worry that allowing emergency use of a COVID-19 vaccine could damage confidence in the shots and make it harder to ever find out how well they really work. Those advisers said it’s critical these massive studies are allowed to run to completion.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

By The Associated Press

CoronavirusDrugs

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Photo from Town of Sylvan Lake Facebook page
Sylvan Lake communities band together on development plan

Sylvan Lake Intermunicipal Development Plan expected to be approved next spring

Tribe restaurant owner Paul Harris, left, consults with manager Brandon Bouchard about how to proceed under pandemic rules that make it hard for eateries to be profitable. (Contributed photo).
New pandemic rules deemed workable for Red Deer retailers

Stricter COVID-19 reduction measures introduced in lead-up to Christmas

Quentin Lee Strawberry
Man accused in 2019 Red Deer murder will stay behind bars

Quentin Strawberry going to trial next year on second-degree murder charge

Dow Chemicals employees recently volunteered at Habitat for Humanity's Blackfalds project. The federal government announced Wednesday that it is also supporting the affordable housing project. Photo contributed
Habitat for Humanity gets funding for Blackfalds housing project

Habitat for Humanity’s Blackfalds housing project will get some support from the… Continue reading

City of Red Deer Mayor Tara Veer (Advocate file photo).
Veer urges indoor mask wearing immediately

We must protect hospital capacity and each other, says Tara Veer

The Alberta government passed new, stricter COVID-19 measures across the province on Tuesday. THE CANADIAN PRESS/Graham Hughes
Here’s a list of Alberta’s new COVID rules

The Alberta government has provided a list of new COVID-19 measures to… Continue reading

A
Red Deer Games Foundation adjusts grant program due to COVID-19 pandemic

The Red Deer Games Foundation announced Wednesday that it will allow athletes… Continue reading

In this undated photo issued by the University of Oxford, a volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
POLL: When a COVID-19 vaccine is available, will you get the shot?

When a COVID-19 vaccine is available, will you get the shot?… Continue reading

The tournament was cancelled because of the ongoing COVID-19 pandemic. (Image courtesy of WHL)
2020 WHL Cup cancelled

A tournament featuring the top under 16 male hockey prospects in Western… Continue reading

TORONTO, ON - DECEMBER, 7  - Susan Delacourt
Logo headshots of Toronto Star staff shot in Star studio.
December 7, 2015
Opinion: Don’t blame Trump for vaccine wait

Canadians will be getting COVID-19 vaccinations after Americans, Justin Trudeau has admitted,… Continue reading

QMJHL Roundup: Armada down Olympiques to extend win streak to seven games

QMJHL Roundup: Armada down Olympiques to extend win streak to seven games

Nashville SC ends Toronto FC’s season with stunning 1-0 extra time upset

Nashville SC ends Toronto FC’s season with stunning 1-0 extra time upset

Juve, Barça, Chelsea, Sevilla advance in Champions League

Juve, Barça, Chelsea, Sevilla advance in Champions League

Most Read